Pharma News

The U.S. Food and Drug Administration expanded the approved use of Imbruvica™ which contains ibrutinib, for chronic lymphocytic leukemia (CLL) patients who have received at least one previous therapy on Wednesday, 12 Feb, 2014. Imbruvica™ is manufactured by Pharmacyclics based at Sunnyvale, California.

For atherosclerotic cardiovascular disease risk reduction, American College of Cardiology and the American Heart Association guidelines recommend initiating moderate or high-intensity statin monotherapy as the first-lin

Mast Therapeutics, Inc., publicly traded biopharmaceutical company headquartered in San Diego, California, announced on 10th feb, 2014 that it has entered into a definitive agreement to acquire Aires Pharmaceuticals, Inc. (Aires), a privately-held, clinical stage pharmaceutical company developing therapies to treat pulmonary vascular disorders such as pulmonary arterial hypertension and pulmonary hypertension due to heart failure.

The Zydus Group announced a breakthrough in its research efforts with Lipaglyn ^TM (Saroglitazar), a novel drug targeted at bridging an unmet healthcare need for treating Diabetic Dyslipidemia or Hypertriglyceridemia in Type II diabetes, not controlled by statins alone. The drug has been approved for launch in India by the Drug Controller General of India (DCGI). With a novel action that offers lipid and glucose lowering effects in one molecule, Lipaglyn ^TM is the first Glitazar to be approved anywhere in the world.

Shree Devi Education Trust situated at Mangalore, Karnataka,India, established in the year 1992 was founded by educationalists having vast experience in the field of college education. The organization is located in the ideal surroundings, 1/2 km from the bus stand, 2 km from railway station and 16 km from the airport. The founder. Chairman of the trust Sri A. Sadananda Shetty is a receipent of the Priyadarshini Indira Gandhi Award.

R. C. Patel College of Pharmacy (RCPIPER) was established in 1992 with the primary objective of providing value based health and technical education to aspiring candidates and mould out of them citizens who will make India proud in the 21st Century. The institute also aims for all-round development of the students to help them realize their full potential and career goals.

CSIR-Central Drug Research Institute, Lucknow is a premier R&D Institute under the aegis of the Council of Scientific and Industrial Research (CSIR), New Delhi which is an autonomous body under Department of Scientific and Industrial Research, Government of India.